Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/cncr.32743 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to Editorial Comment on "Does Severity of Chronic Urinary Retention as Estimated by Preoperative Residual Urine Estimation Negatively Impact the Outcome of Holmium Laser Enucleation of the Prostate?".
Urology
October 2024
Desai Sethi Urology Institute, University of Miami, Miller School of Medicine, Miami, FL. Electronic address:
Prediction of radiotherapy toxicity: 20 years of COPERNIC radiosensitivity diagnosis procedure.
Cancer Radiother
October 2024
UMR1296 « Radiations : défense, santé, environnement », Institut national de la santé et de la recherche médicale (Inserm), rue Laennec, 69008 Lyon, France; Department of Radiation Oncology, American University of Beirut Medical Center, Riad El-Solh, Beirut 1107-2020, Lebanon; Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Bliss Street, 11-0236 Riad El-Solh, Beirut 1107-2020, Lebanon.
Purpose: Since 2004, in the frame of the care pathway, our Research Unit has replied to the demand of expertise of radiation oncologists about the individual radiosensitivity of some of their patients. This procedure, called COPERNIC, is based on a skin biopsy and the radiation-induced nucleoshuttling of the ATM protein (the RIANS model), a major actor of DNA break repair and signaling. In 2016, with the first 117COPERNIC fibroblast lines, we obtained a significant correlation between the maximum number of the nuclear ATM foci, pATM, and the CTCAE severity grade of the post-radiotherapy tissue reactions.
View Article and Find Full Text PDFReply to the letter, "Residual shunt after patent foramen ovale closure: The devil is in the details!" regarding article "Relationship between patent foramen ovale anatomical features and residual shunt after patent foramen ovale closure".
Catheter Cardiovasc Interv
September 2024
Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Reply to: "Therapeutic Drug Monitoring of Oral Oncology Drugs: Another Example of Maslow's Hammer" and "Therapeutic Drug Monitoring of Oral Oncology Drugs: Finding the Right Nails".
Clin Pharmacol Ther
September 2024
Department of Pharmacology and Clinical Investigation Center (CIC-1901), Pitié-Salpêtrière Hospital, AP-HP Sorbonne Université, Paris, France.
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. Reply.
N Engl J Med
May 2024
Leeds Cancer Centre, Leeds, United Kingdom
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!